Sharon Mates - 22 Jan 2026 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director
Signature
/s/ Sharon Mates
Issuer symbol
BNTC
Transactions as of
22 Jan 2026
Net transactions value
$0
Form type
4
Filing time
26 Jan 2026, 16:10:15 UTC
Previous filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mates Sharon Director C/O BENITEC BIOPHARMA INC., 3940 TRUST WAY, HAYWARD /s/ Sharon Mates 26 Jan 2026 0001585699

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +31,500 $0.000000 31,500 22 Jan 2026 Common Stock 31,500 $12.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.